Abstract
Dystonia is a movement disorder characterised by involuntary, extended, patterned, and often repetitive muscle contractions of skeletal muscles, frequently causing twisting movements or abnormal postures. Recent studies have shown that stress and coffee consumption can precipitate dystonic attacks. Many people, due to their diligent life schedules and increased physical inactivity due to less work-life balance, have been identified as the major cause of this neurological movement disorder. The action of caffeine and other CNS stimulants may be related to dystonic episodes in an individual. Cervical dystonia is specifically characterised by involuntary muscle contraction of the trapezius muscle, pain in the cervical region, numbness in one or both arms, and restricted movement. Proper understanding and management of spasmodic torticollis are necessary to avoid discomfort and progress towards a healthy life. The case study aims to highlight the role of physical activity along with proper work-life balance to live a healthy lifestyle and minimise the frequency of muscle spasm attacks caused by spasmodic torticollis. The role of clinicians such as physicians and clinical pharmacists in understanding and managing the disease is critical and crucial for a better quality of life and leading a stress-free life.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmaceutical Science,Pharmacology
Reference9 articles.
1. Hains F, Donat J, Cassidy JD. Spasmodic torticollis: a case study. J Can Chiropr Assoc. 1992 Sep;36(3):146-51.
2. Hogg E, Tagliati M. Overuse cervical dystonia: a case report and literature review. Tremor Other Hyperkinet Mov (NY). 2016 Sep;6:413. doi: 10.7916/D8959HR1, PMID 27708983.
3. Richter A, Hamann M. Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia. Br J Pharmacol. 2001 Sep;134(2):343-52. doi: 10.1038/sj.bjp.0704268, PMID 11564652.
4. Fredholm BB. Astra award lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol. 1995 Feb;76(2):93-101. doi: 10.1111/j.1600-0773.1995.tb00111.x, PMID 7746802.
5. Witenko C, Moorman Li R, Motycka C, Duane K, Hincapie Castillo J, Leonard P. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. PT. 2014 Jun;39(6):427-35. PMID 25050056.